Drug Trial Radar · NCT04580394
Crossover Trial of AD109 in Obstructive Sleep Apnea
Last checked: Nov 19, 2026Latest source record: Jan 31, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Oct 27, 2020
Primary completion
May 28, 2021
Study completion May 28, 2021
Sponsor
- Lead sponsor
- ApnimedIndustry
- Sponsor type
- Industry
- First posted
- Oct 8, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 25 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, 4-period, placebo-controlled, crossover, phase 2 clinical study to examine the efficacy and safety of AD109 versus its individual components or placebo in patients with obstructive sleep apnea.
Conditions
- Obstructive Sleep Apnea
Interventions
AD109Drug
Oral administration before bed
AtomoxetineDrug
Oral administration before bed
R-oxybutyninDrug
Oral administration before bed
PlaceboDrug
Oral administration before bed
Digit System Substitution TestDiagnostic test
a neuropsychological test sensitive to brain damage, dementia, age and depression where numbers are assigned symbols. Under each digit the subject should write down the corresponding symbol as fast as possible. The number of correct symbols within the allowed time is measured.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Hypoxic Burden (HB) Log10HB[(%*Min)/Hour]Time frame: 1 night (treatment duration) (0-8 hours collected continuously)
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Preferred Research Partners, Inc.
Little Rock, Arkansas
Empire Clinical Research
Pomona, California
Yale University
New Haven, Connecticut
Teradan Clinical Trials
Brandon, Florida
Clinical Trials of Florida
Miami, Florida
The Neurological Center of North Georgia
Gainesville, Georgia
CTI Clinical Research Center
Cincinnati, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.